Verastem reported $95.66M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
AstraZeneca AZN:LN 39744M 24068M
Curis CRIS:US $ 102.91M 9.56M
Cytokinetics CYTK:US $ 249.02M 232.53M
Epizyme EPZM:US $ 15.38M 52.25M
Gilead Sciences GILD:US $ 21471M 1768M
Immunogen IMGN:US $ 77.09M 8.63M
Laboratory Of America LH:US $ 10524.5M 279.4M
Novartis NOVN:VX SF 56771M 2729M
Tg Therapeutics TGTX:US $ 311.52M 71.61M
Verastem VSTM:US $ 95.66M 7.45M
YTE INCY:US $ 3148.66M 212.8M
Ziopharm Oncology ZIOP:US $ 68.71M 19.57M